Product Name

  • Name

    5-ANDROSTEN-3-BETA, 7-BETA-DIOL-17-ONE

  • EINECS
  • CAS No. 2487-48-1
  • Article Data48
  • CAS DataBase
  • Density 1.194 g/cm3
  • Solubility
  • Melting Point 215-216 °C(Solv: acetone (67-64-1); cyclohexane (110-82-7))
  • Formula C19H28O3
  • Boiling Point 473.271 °C at 760 mmHg
  • Molecular Weight 304.43
  • Flash Point 254.138 °C
  • Transport Information
  • Appearance
  • Safety
  • Risk Codes
  • Molecular Structure Molecular Structure of 2487-48-1 (5-ANDROSTEN-3-BETA, 7-BETA-DIOL-17-ONE)
  • Hazard Symbols
  • Synonyms Androst-5-en-17-one,3β,7b-dihydroxy- (7CI,8CI);(3β,7β,8ξ,9ξ,14ξ)-3,7-dihydroxyandrost-5-en-17-one;5-Androsten-3β,7β-diol-17-one;
  • PSA 57.53000
  • LogP 2.85000

Synthetic route

7β-hydroxy-17-oxoandrost-5-ene-3β-yl acetate

7β-hydroxy-17-oxoandrost-5-ene-3β-yl acetate

5-androsten-3β,7β-diol-17-one
2487-48-1

5-androsten-3β,7β-diol-17-one

Conditions
ConditionsYield
With sodium carbonate In methanol; water for 1.25h; Heating;83%
With water; sodium carbonate In methanol for 3h; Reflux;75%
dehydroepiandrosterone
53-43-0

dehydroepiandrosterone

5-androsten-3β,7β-diol-17-one
2487-48-1

5-androsten-3β,7β-diol-17-one

Conditions
ConditionsYield
With Dipodia gossypina54%
mit Hilfe einer Rhizopus-Art;
With Botryodiplodia malorum In phosphate buffer; dimethyl sulfoxide at 30℃; for 72h; pH=6.0; Microbiological reaction;
dehydroepiandrosterone
53-43-0

dehydroepiandrosterone

A

5-androstene-3β-ol-7,17-dione
566-19-8

5-androstene-3β-ol-7,17-dione

B

3β,7α-dihydroxyandrost-5-ene-17-one
2487-48-1, 7522-54-5, 62357-03-3, 53-00-9

3β,7α-dihydroxyandrost-5-ene-17-one

C

5-androsten-3β,7β-diol-17-one
2487-48-1

5-androsten-3β,7β-diol-17-one

Conditions
ConditionsYield
With Mortierella isabellina AM212 fungal strain for 12h; Enzymatic reaction;A 6%
B 53.5%
C 24%
With Absidia coerulea AM93 In acetone at 20℃; for 8h; Time; Enzymatic reaction;A 5.5%
B 22%
C 49%
dehydroepiandrosterone
53-43-0

dehydroepiandrosterone

A

3β,7α-dihydroxyandrost-5-ene-17-one
2487-48-1, 7522-54-5, 62357-03-3, 53-00-9

3β,7α-dihydroxyandrost-5-ene-17-one

B

5-androsten-3β,7β-diol-17-one
2487-48-1

5-androsten-3β,7β-diol-17-one

Conditions
ConditionsYield
With Aspergillus wentii MRC 200316 In water; N,N-dimethyl-formamide at 27℃; for 120h; pH=7.2; Culture medium; Microbiological reaction; Enzymatic reaction;A 51%
B 12%
With dipotassium hydrogenphosphate; magnesium sulfate heptahydrate; Maltose for 96h; Enzymatic reaction;A 43.6%
B 12.6%
With Mucor racemosus In acetone at 27℃; for 96h;A 40.9%
B 18%
dehydroepiandrosterone
53-43-0

dehydroepiandrosterone

A

3β,7α-dihydroxyandrost-5-ene-17-one
2487-48-1, 7522-54-5, 62357-03-3, 53-00-9

3β,7α-dihydroxyandrost-5-ene-17-one

B

5-androsten-3β,7β-diol-17-one
2487-48-1

5-androsten-3β,7β-diol-17-one

C

3β,5α,6β-trihydroxy-5α-androstan-17-one
10161-36-1

3β,5α,6β-trihydroxy-5α-androstan-17-one

D

3β,11α-dihydroxyandrost-5-en-17-one
39663-17-7

3β,11α-dihydroxyandrost-5-en-17-one

Conditions
ConditionsYield
With Cephalosporium aphidicola In ethanol; dimethyl sulfoxide for 192h;A 31%
B 25%
C 6%
D 6%
dehydroepiandrosterone
53-43-0

dehydroepiandrosterone

A

3β,7α-dihydroxyandrost-5-ene-17-one
2487-48-1, 7522-54-5, 62357-03-3, 53-00-9

3β,7α-dihydroxyandrost-5-ene-17-one

B

5-androsten-3β,7β-diol-17-one
2487-48-1

5-androsten-3β,7β-diol-17-one

C

3β-hydroxy-13,17-secoandrost-5-ene-17,13α-lactone
2061-72-5

3β-hydroxy-13,17-secoandrost-5-ene-17,13α-lactone

D

testololactone
4416-57-3

testololactone

Conditions
ConditionsYield
With Aspergillus tamarii MRC 72400 In N,N-dimethyl-formamide at 25℃; for 120h; Baeyer-Villiger oxidation; Microbiological reaction;A 24%
B 13%
C 28%
D 6%
prasterone acetate
853-23-6

prasterone acetate

A

5-androstene-3β-ol-7,17-dione
566-19-8

5-androstene-3β-ol-7,17-dione

B

3β,7α-dihydroxyandrost-5-ene-17-one
2487-48-1, 7522-54-5, 62357-03-3, 53-00-9

3β,7α-dihydroxyandrost-5-ene-17-one

C

5-androsten-3β,7β-diol-17-one
2487-48-1

5-androsten-3β,7β-diol-17-one

D

3β,14α-dihydroxyandrost-5-en-7,17-dione
58211-52-2

3β,14α-dihydroxyandrost-5-en-7,17-dione

Conditions
ConditionsYield
With Cunninghamella elegans In ethanol for 72h; Further byproducts given;A 5.4%
B 26.8%
C 9%
D 1.1%
With Cunninghamella elegans In ethanol for 72h; Further byproducts given;A 5.4%
B 26.8%
C 9%
D 1.1%
Benzoic acid (3S,7R,8R,9S,10R,13S,14S)-7-isobutyryloxy-10,13-dimethyl-17-oxo-2,3,4,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-3-yl ester
188176-04-7

Benzoic acid (3S,7R,8R,9S,10R,13S,14S)-7-isobutyryloxy-10,13-dimethyl-17-oxo-2,3,4,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-3-yl ester

5-androsten-3β,7β-diol-17-one
2487-48-1

5-androsten-3β,7β-diol-17-one

Conditions
ConditionsYield
With sodium hydroxide In tetrahydrofuran; methanol at 60℃; for 29h;26%
dehydroepiandrosterone
53-43-0

dehydroepiandrosterone

A

6α-hydroxy-androst-4-ene-3,17-dione
24704-84-5

6α-hydroxy-androst-4-ene-3,17-dione

B

5α-androst-3,6,17-trione
2243-05-2

5α-androst-3,6,17-trione

C

3β,7α-dihydroxyandrost-5-ene-17-one
2487-48-1, 7522-54-5, 62357-03-3, 53-00-9

3β,7α-dihydroxyandrost-5-ene-17-one

D

5-androsten-3β,7β-diol-17-one
2487-48-1

5-androsten-3β,7β-diol-17-one

E

7α-hydroxyandrost-4-ene-3,17-dione
62-84-0, 31427-20-0

7α-hydroxyandrost-4-ene-3,17-dione

F

6β-hydroxy-4-androstene-3,17-dione
63-00-3

6β-hydroxy-4-androstene-3,17-dione

Conditions
ConditionsYield
With Cladosporium sphaerospermum MRC 70266 In water; N,N-dimethyl-formamide at 28℃; for 120h; Enzymatic reaction;A 5%
B 4%
C 20%
D 4%
E 6%
F 15%
dehydroepiandrosterone
53-43-0

dehydroepiandrosterone

A

5-androstene-3β-ol-7,17-dione
566-19-8

5-androstene-3β-ol-7,17-dione

B

3β,7α-dihydroxyandrost-5-ene-17-one
2487-48-1, 7522-54-5, 62357-03-3, 53-00-9

3β,7α-dihydroxyandrost-5-ene-17-one

C

5-androsten-3β,7β-diol-17-one
2487-48-1

5-androsten-3β,7β-diol-17-one

D

3β,7β-dihydroxy-5β,6β-epoxyandrostan-17-one

3β,7β-dihydroxy-5β,6β-epoxyandrostan-17-one

E

3β,4β,7β-trihydroxyandrost-5-en-17-one

3β,4β,7β-trihydroxyandrost-5-en-17-one

F

3β,7α-dihydroxy-5β,6β-epoxyandrostan-17-one

3β,7α-dihydroxy-5β,6β-epoxyandrostan-17-one

G

3β,4β,7α-trihydroxyandrost-5-en-17-one

3β,4β,7α-trihydroxyandrost-5-en-17-one

Conditions
ConditionsYield
With Ulocladium chartarum MRC 72584 In water; N,N-dimethyl-formamide at 28℃; for 120h; Enzymatic reaction;A 6%
B 12%
C 16%
D 3%
E 4%
F 2%
G 3%
3α,5-cyclo-5α-androstan-6β-ol-17-one
663-39-8

3α,5-cyclo-5α-androstan-6β-ol-17-one

A

3β,7α-dihydroxyandrost-5-ene-17-one
2487-48-1, 7522-54-5, 62357-03-3, 53-00-9

3β,7α-dihydroxyandrost-5-ene-17-one

B

5-androsten-3β,7β-diol-17-one
2487-48-1

5-androsten-3β,7β-diol-17-one

C

3β,14α-dihydroxy-androst-5-en-17-one
94991-86-3

3β,14α-dihydroxy-androst-5-en-17-one

D

14α-hydroxy-3α,5-cycloandrostane-6,17-dione

14α-hydroxy-3α,5-cycloandrostane-6,17-dione

Conditions
ConditionsYield
With culture of Cephalosporium aphidicola In ethanol; dimethyl sulfoxide for 192h; Oxidation; hydroxylation; rearrangement; biotransformation; Further byproducts given;A 15%
B 13%
C 6%
D 2%
3α,5-cyclo-5α-androstan-6β-ol-17-one
663-39-8

3α,5-cyclo-5α-androstan-6β-ol-17-one

A

3β,7α-dihydroxyandrost-5-ene-17-one
2487-48-1, 7522-54-5, 62357-03-3, 53-00-9

3β,7α-dihydroxyandrost-5-ene-17-one

B

5-androsten-3β,7β-diol-17-one
2487-48-1

5-androsten-3β,7β-diol-17-one

C

3β,5α,6β-trihydroxy-5α-androstan-17-one
10161-36-1

3β,5α,6β-trihydroxy-5α-androstan-17-one

D

6β,14α-dihydroxy-3α,5-cycloandrostan-17-one
24357-28-6

6β,14α-dihydroxy-3α,5-cycloandrostan-17-one

Conditions
ConditionsYield
With culture of Cephalosporium aphidicola In ethanol; dimethyl sulfoxide for 192h; Oxidation; hydroxylation; rearrangement; biotransformation; Further byproducts given;A 15%
B 13%
C 9%
D 10%
Conditions
ConditionsYield
With dipotassium hydrogenphosphate; magnesium sulfate heptahydrate; Maltose for 96h; Enzymatic reaction;A 8.9%
B 11.1%
prasterone acetate
853-23-6

prasterone acetate

A

5-androstene-3β-ol-7,17-dione
566-19-8

5-androstene-3β-ol-7,17-dione

B

5-androsten-3β,7β-diol-17-one
2487-48-1

5-androsten-3β,7β-diol-17-one

C

5,6β-epoxy-3β,12α-dihydroxy-5β-androstan-17-one
58324-06-4

5,6β-epoxy-3β,12α-dihydroxy-5β-androstan-17-one

D

3β,14α-dihydroxyandrost-5-en-7,17-dione
58211-52-2

3β,14α-dihydroxyandrost-5-en-7,17-dione

Conditions
ConditionsYield
With Cunninghamella elegans In ethanol for 72h; Further byproducts given;A 5.4%
B 9%
C 4.1%
D 1.1%
5-androsten-3β,7β-diol-17-one ethylene ketal 3-tert-butyldimethylsilyl ether
202415-78-9

5-androsten-3β,7β-diol-17-one ethylene ketal 3-tert-butyldimethylsilyl ether

5-androsten-3β,7β-diol-17-one
2487-48-1

5-androsten-3β,7β-diol-17-one

Conditions
ConditionsYield
With hydrogenchloride In tetrahydrofuran; methanol
3β-acetoxy-20-hydroxyiminopregna-5,16-diene
23549-24-8, 23549-26-0, 2174-13-2

3β-acetoxy-20-hydroxyiminopregna-5,16-diene

5-androsten-3β,7β-diol-17-one
2487-48-1

5-androsten-3β,7β-diol-17-one

Conditions
ConditionsYield
Multi-step reaction with 2 steps
1.1: POCl3; pyridine / toluene / 4 h / 10 - 20 °C
1.2: 51.8 percent / KOH / methanol / Heating
2.1: 18 percent / Mucor racemosus / acetone / 96 h / 27 °C
View Scheme
16-dehydropregnenolone acetate
979-02-2

16-dehydropregnenolone acetate

5-androsten-3β,7β-diol-17-one
2487-48-1

5-androsten-3β,7β-diol-17-one

Conditions
ConditionsYield
Multi-step reaction with 3 steps
1.1: 87 percent / NH2OH*HCl / pyridine; ethanol; H2O / 0.5 h / Heating
2.1: POCl3; pyridine / toluene / 4 h / 10 - 20 °C
2.2: 51.8 percent / KOH / methanol / Heating
3.1: 18 percent / Mucor racemosus / acetone / 96 h / 27 °C
View Scheme
diosgenin
512-04-9

diosgenin

5-androsten-3β,7β-diol-17-one
2487-48-1

5-androsten-3β,7β-diol-17-one

Conditions
ConditionsYield
Multi-step reaction with 4 steps
1.1: NH4Cl / pyridine / Heating
1.2: CrO3; CH3COOH / 1,2-dichloro-ethane / 0 °C
1.3: AcONa*3H2O / Heating
2.1: 87 percent / NH2OH*HCl / pyridine; ethanol; H2O / 0.5 h / Heating
3.1: POCl3; pyridine / toluene / 4 h / 10 - 20 °C
3.2: 51.8 percent / KOH / methanol / Heating
4.1: 18 percent / Mucor racemosus / acetone / 96 h / 27 °C
View Scheme
5-androsten-7,17-dione-3β-ol ethylene ketal tert-butyldimethylsilyl ether
202415-77-8

5-androsten-7,17-dione-3β-ol ethylene ketal tert-butyldimethylsilyl ether

5-androsten-3β,7β-diol-17-one
2487-48-1

5-androsten-3β,7β-diol-17-one

Conditions
ConditionsYield
Multi-step reaction with 2 steps
1: NaBH4; CeCl3
2: HCl / methanol; tetrahydrofuran
View Scheme
3β-benzoyloxy-androst-5-en-17-one
83205-52-1, 2080-86-6

3β-benzoyloxy-androst-5-en-17-one

5-androsten-3β,7β-diol-17-one
2487-48-1

5-androsten-3β,7β-diol-17-one

Conditions
ConditionsYield
Multi-step reaction with 8 steps
1: 91 percent / NaBH4 / CH2Cl2 / 2 h / 10 °C
2: 81 percent / pyridine / 48 h / Ambient temperature
3: 68 percent / CrO3, 3,5-dimethylpyrazole / CH2Cl2 / 3 h / -20 °C
4: 83 percent / CeCl3*5H2O, NaBH4 / tetrahydrofuran; methanol / 0.08 h
5: 90 percent / pyridine / 1 h / 0 °C
6: 36 percent / conc. HCl / CHCl3; methanol / 25 h / Ambient temperature
7: 93 percent / Jones reagent / acetone / 0.08 h / Ambient temperature
8: 26 percent / aq. NaOH / tetrahydrofuran; methanol / 29 h / 60 °C
View Scheme
Benzoic acid (3S,8R,9S,10R,13S,14S,17S)-17-hydroxy-10,13-dimethyl-2,3,4,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-3-yl ester
96073-67-5

Benzoic acid (3S,8R,9S,10R,13S,14S,17S)-17-hydroxy-10,13-dimethyl-2,3,4,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-3-yl ester

5-androsten-3β,7β-diol-17-one
2487-48-1

5-androsten-3β,7β-diol-17-one

Conditions
ConditionsYield
Multi-step reaction with 7 steps
1: 81 percent / pyridine / 48 h / Ambient temperature
2: 68 percent / CrO3, 3,5-dimethylpyrazole / CH2Cl2 / 3 h / -20 °C
3: 83 percent / CeCl3*5H2O, NaBH4 / tetrahydrofuran; methanol / 0.08 h
4: 90 percent / pyridine / 1 h / 0 °C
5: 36 percent / conc. HCl / CHCl3; methanol / 25 h / Ambient temperature
6: 93 percent / Jones reagent / acetone / 0.08 h / Ambient temperature
7: 26 percent / aq. NaOH / tetrahydrofuran; methanol / 29 h / 60 °C
View Scheme
Benzoic acid (3S,8R,9S,10R,13S,14S,17S)-17-acetoxy-10,13-dimethyl-2,3,4,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-3-yl ester
188175-90-8

Benzoic acid (3S,8R,9S,10R,13S,14S,17S)-17-acetoxy-10,13-dimethyl-2,3,4,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-3-yl ester

5-androsten-3β,7β-diol-17-one
2487-48-1

5-androsten-3β,7β-diol-17-one

Conditions
ConditionsYield
Multi-step reaction with 6 steps
1: 68 percent / CrO3, 3,5-dimethylpyrazole / CH2Cl2 / 3 h / -20 °C
2: 83 percent / CeCl3*5H2O, NaBH4 / tetrahydrofuran; methanol / 0.08 h
3: 90 percent / pyridine / 1 h / 0 °C
4: 36 percent / conc. HCl / CHCl3; methanol / 25 h / Ambient temperature
5: 93 percent / Jones reagent / acetone / 0.08 h / Ambient temperature
6: 26 percent / aq. NaOH / tetrahydrofuran; methanol / 29 h / 60 °C
View Scheme
Benzoic acid (3S,7R,8R,9S,10R,13S,14S,17S)-17-acetoxy-7-hydroxy-10,13-dimethyl-2,3,4,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-3-yl ester
188176-01-4

Benzoic acid (3S,7R,8R,9S,10R,13S,14S,17S)-17-acetoxy-7-hydroxy-10,13-dimethyl-2,3,4,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-3-yl ester

5-androsten-3β,7β-diol-17-one
2487-48-1

5-androsten-3β,7β-diol-17-one

Conditions
ConditionsYield
Multi-step reaction with 4 steps
1: 90 percent / pyridine / 1 h / 0 °C
2: 36 percent / conc. HCl / CHCl3; methanol / 25 h / Ambient temperature
3: 93 percent / Jones reagent / acetone / 0.08 h / Ambient temperature
4: 26 percent / aq. NaOH / tetrahydrofuran; methanol / 29 h / 60 °C
View Scheme
Benzoic acid (3S,7R,8R,9S,10R,13S,14S,17S)-17-hydroxy-7-isobutyryloxy-10,13-dimethyl-2,3,4,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-3-yl ester
188176-03-6

Benzoic acid (3S,7R,8R,9S,10R,13S,14S,17S)-17-hydroxy-7-isobutyryloxy-10,13-dimethyl-2,3,4,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-3-yl ester

5-androsten-3β,7β-diol-17-one
2487-48-1

5-androsten-3β,7β-diol-17-one

Conditions
ConditionsYield
Multi-step reaction with 2 steps
1: 93 percent / Jones reagent / acetone / 0.08 h / Ambient temperature
2: 26 percent / aq. NaOH / tetrahydrofuran; methanol / 29 h / 60 °C
View Scheme
17β-acetoxy-3β-benzoyloxy-5-androsten-7-one
188176-00-3

17β-acetoxy-3β-benzoyloxy-5-androsten-7-one

5-androsten-3β,7β-diol-17-one
2487-48-1

5-androsten-3β,7β-diol-17-one

Conditions
ConditionsYield
Multi-step reaction with 5 steps
1: 83 percent / CeCl3*5H2O, NaBH4 / tetrahydrofuran; methanol / 0.08 h
2: 90 percent / pyridine / 1 h / 0 °C
3: 36 percent / conc. HCl / CHCl3; methanol / 25 h / Ambient temperature
4: 93 percent / Jones reagent / acetone / 0.08 h / Ambient temperature
5: 26 percent / aq. NaOH / tetrahydrofuran; methanol / 29 h / 60 °C
View Scheme
Benzoic acid (3S,7R,8R,9S,10R,13S,14S,17S)-17-acetoxy-7-isobutyryloxy-10,13-dimethyl-2,3,4,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-3-yl ester
188176-02-5

Benzoic acid (3S,7R,8R,9S,10R,13S,14S,17S)-17-acetoxy-7-isobutyryloxy-10,13-dimethyl-2,3,4,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-3-yl ester

5-androsten-3β,7β-diol-17-one
2487-48-1

5-androsten-3β,7β-diol-17-one

Conditions
ConditionsYield
Multi-step reaction with 3 steps
1: 36 percent / conc. HCl / CHCl3; methanol / 25 h / Ambient temperature
2: 93 percent / Jones reagent / acetone / 0.08 h / Ambient temperature
3: 26 percent / aq. NaOH / tetrahydrofuran; methanol / 29 h / 60 °C
View Scheme
3-O-acetyl-7-oxo-dehydroepiandrosterone
1449-61-2

3-O-acetyl-7-oxo-dehydroepiandrosterone

A

3β,7α-dihydroxyandrost-5-ene-17-one
2487-48-1, 7522-54-5, 62357-03-3, 53-00-9

3β,7α-dihydroxyandrost-5-ene-17-one

B

5-androsten-3β,7β-diol-17-one
2487-48-1

5-androsten-3β,7β-diol-17-one

A

testosterone
58-22-0

testosterone

B

5-androsten-3β,7β-diol-17-one
2487-48-1

5-androsten-3β,7β-diol-17-one

C

Androst-5-ene-3beta,7alpha,17beta-triol
2697-85-0, 62357-04-4, 2226-66-6

Androst-5-ene-3beta,7alpha,17beta-triol

D

5-androstene-3β,7β,17β-triol
2697-85-0

5-androstene-3β,7β,17β-triol

Conditions
ConditionsYield
With water In ethanol for 120h; Microbiological reaction;
5-androsten-3β,7β-diol-17-one
2487-48-1

5-androsten-3β,7β-diol-17-one

1,1,1,3,3,3-hexamethyl-disilazane
999-97-3

1,1,1,3,3,3-hexamethyl-disilazane

3β,7β-bis-(trimethylsiloxy)-5-androsten-17-one
56210-85-6

3β,7β-bis-(trimethylsiloxy)-5-androsten-17-one

Conditions
ConditionsYield
saccharin In acetonitrile for 8h; Reflux; Inert atmosphere; Industry scale;81%
saccharin In acetonitrile for 8h; Reflux; Inert atmosphere;81%
5-androsten-3β,7β-diol-17-one
2487-48-1

5-androsten-3β,7β-diol-17-one

3β,7β-diacetoxyandrost-5-en-17-one
67576-47-0

3β,7β-diacetoxyandrost-5-en-17-one

C24H32O3

C24H32O3

Conditions
ConditionsYield
With scandium tris(trifluoromethanesulfonate) In acetonitrile78%
5-androsten-3β,7β-diol-17-one
2487-48-1

5-androsten-3β,7β-diol-17-one

3β,7β,11α-trihydroxy-5-androsten-17-one
537718-07-3

3β,7β,11α-trihydroxy-5-androsten-17-one

Conditions
ConditionsYield
With Apergillus ochraceus75%
With Aspergillus ochraceus ATCC 18500 (NRRL 405) Microbiological reaction;
5-androsten-3β,7β-diol-17-one
2487-48-1

5-androsten-3β,7β-diol-17-one

N-methoxylamine hydrochloride
593-56-6

N-methoxylamine hydrochloride

dimethylisopropylsilylimidazole
81452-04-2

dimethylisopropylsilylimidazole

(3S,7R,8R,9S,10R,13S,14S)-7-Hydroxy-3-(isopropyl-dimethyl-silanyloxy)-10,13-dimethyl-1,2,3,4,7,8,9,10,11,12,13,14,15,16-tetradecahydro-cyclopenta[a]phenanthren-17-one O-methyl-oxime

(3S,7R,8R,9S,10R,13S,14S)-7-Hydroxy-3-(isopropyl-dimethyl-silanyloxy)-10,13-dimethyl-1,2,3,4,7,8,9,10,11,12,13,14,15,16-tetradecahydro-cyclopenta[a]phenanthren-17-one O-methyl-oxime

Conditions
ConditionsYield
Stage #1: 5-androsten-3β,7β-diol-17-one; N-methoxylamine hydrochloride In pyridine at 60℃; for 1h;
Stage #2: dimethylisopropylsilylimidazole In pyridine at 60℃; for 0.5h;
5-androsten-3β,7β-diol-17-one
2487-48-1

5-androsten-3β,7β-diol-17-one

N-methoxylamine hydrochloride
593-56-6

N-methoxylamine hydrochloride

N-dimethylethylsilyl-imidazole
62365-34-8

N-dimethylethylsilyl-imidazole

(3S,7R,8R,9S,10R,13S,14S)-3-(Ethyl-dimethyl-silanyloxy)-7-hydroxy-10,13-dimethyl-1,2,3,4,7,8,9,10,11,12,13,14,15,16-tetradecahydro-cyclopenta[a]phenanthren-17-one O-methyl-oxime

(3S,7R,8R,9S,10R,13S,14S)-3-(Ethyl-dimethyl-silanyloxy)-7-hydroxy-10,13-dimethyl-1,2,3,4,7,8,9,10,11,12,13,14,15,16-tetradecahydro-cyclopenta[a]phenanthren-17-one O-methyl-oxime

Conditions
ConditionsYield
Stage #1: 5-androsten-3β,7β-diol-17-one; N-methoxylamine hydrochloride In pyridine at 60℃; for 1h;
Stage #2: N-dimethylethylsilyl-imidazole In pyridine at 60℃; for 0.5h;
5-androsten-3β,7β-diol-17-one
2487-48-1

5-androsten-3β,7β-diol-17-one

N-methoxylamine hydrochloride
593-56-6

N-methoxylamine hydrochloride

1-(Trimethylsilyl)imidazole
18156-74-6

1-(Trimethylsilyl)imidazole

(3S,7R,8R,9S,10R,13S,14S)-7-Hydroxy-10,13-dimethyl-3-trimethylsilanyloxy-1,2,3,4,7,8,9,10,11,12,13,14,15,16-tetradecahydro-cyclopenta[a]phenanthren-17-one O-methyl-oxime

(3S,7R,8R,9S,10R,13S,14S)-7-Hydroxy-10,13-dimethyl-3-trimethylsilanyloxy-1,2,3,4,7,8,9,10,11,12,13,14,15,16-tetradecahydro-cyclopenta[a]phenanthren-17-one O-methyl-oxime

Conditions
ConditionsYield
Stage #1: 5-androsten-3β,7β-diol-17-one; N-methoxylamine hydrochloride In pyridine at 60℃; for 1h;
Stage #2: 1-(Trimethylsilyl)imidazole In pyridine at 60℃; for 0.5h;
5-androsten-3β,7β-diol-17-one
2487-48-1

5-androsten-3β,7β-diol-17-one

(1S,2S,4aS,4bR,7S,10R,10aR)-1-Carboxymethyl-7,10-dihydroxy-2,4b-dimethyl-1,2,3,4,4a,4b,5,6,7,8,10,10a-dodecahydro-phenanthrene-2-carboxylic acid

(1S,2S,4aS,4bR,7S,10R,10aR)-1-Carboxymethyl-7,10-dihydroxy-2,4b-dimethyl-1,2,3,4,4a,4b,5,6,7,8,10,10a-dodecahydro-phenanthrene-2-carboxylic acid

Conditions
ConditionsYield
With potassium hydroxide; iodine In methanol; water at 20℃; for 16h;
5-androsten-3β,7β-diol-17-one
2487-48-1

5-androsten-3β,7β-diol-17-one

tert-butyldimethylsilyl chloride
18162-48-6

tert-butyldimethylsilyl chloride

C31H56O3Si2
1016226-91-7

C31H56O3Si2

Conditions
ConditionsYield
With 1H-imidazole In N,N-dimethyl-formamide at 20℃;

5-Androsten-3beta,7beta-diol-17-one Specification

The 5-Androsten-3beta,7beta-diol-17-one, with the CAS registry number 2487-48-1, has the systematic name of (3β,7β,8ξ,9ξ,14ξ)-3,7-dihydroxyandrost-5-en-17-one. It belongs to the product category of Steroid. And the molecular formula of the chemical is C19H28O3.

The characteristics of 5-Androsten-3beta,7beta-diol-17-one are as followings: (1)ACD/LogP: 1.29; (2)# of Rule of 5 Violations: 0; (3)ACD/LogD (pH 5.5): 2; (4)ACD/LogD (pH 7.4): 2; (5)ACD/BCF (pH 5.5): 11; (6)ACD/BCF (pH 7.4): 11; (7)ACD/KOC (pH 5.5): 195; (8)ACD/KOC (pH 7.4): 195; (9)#H bond acceptors: 3; (10)#H bond donors: 2; (11)#Freely Rotating Bonds: 2; (12)Polar Surface Area: 57.53 Å2; (13)Index of Refraction: 1.578; (14)Molar Refractivity: 84.626 cm3; (15)Molar Volume: 254.951 cm3; (16)Polarizability: 33.548×10-24cm3; (17)Surface Tension: 50.195 dyne/cm; (18)Density: 1.194 g/cm3; (19)Flash Point: 254.138 °C; (20)Enthalpy of Vaporization: 84.887 kJ/mol; (21)Boiling Point: 473.271 °C at 760 mmHg; (22)Vapour Pressure: 0 mmHg at 25°C.

Addtionally, the following datas could be converted into the molecular structure:
(1)SMILES: O=C3[C@]2(CCC1[C@@]4(C(=C/[C@H](O)C1C2CC3)\C[C@@H](O)CC4)C)C
(2)InChI: InChI=1/C19H28O3/c1-18-7-5-12(20)9-11(18)10-15(21)17-13-3-4-16(22)19(13,2)8-6-14(17)18/h10,12-15,17,20-21H,3-9H2,1-2H3/t12-,13?,14?,15-,17?,18-,19-/m0/s1
(3)InChIKey: OLPSAOWBSPXZEA-XAAWLDLRBV

Post buying leads

About|Contact|Cas|Product Name|Molecular|Country|Encyclopedia

Message|New Cas|MSDS|Service|Advertisement|CAS DataBase|Article Data|Manufacturers | Chemical Catalog

©2008 LookChem.com,License: ICP

NO.:Zhejiang16009103

complaints:service@lookchem.com Desktop View